Pictet Asset Management (Switzerland)’s Inspire Medical Systems INSP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
$1.09M Hold
3,363
﹤0.01% 976
2023
Q1
$787K Buy
3,363
+96
+3% +$24.3K ﹤0.01% 1060
2022
Q4
$823K Buy
3,267
+1,527
+88% +$326K ﹤0.01% 1059
2022
Q3
$309K Hold
1,740
﹤0.01% 1228
2022
Q2
$318K Hold
1,740
﹤0.01% 1247
2022
Q1
$447K Buy
1,740
+86
+5% +$19.7K ﹤0.01% 1201
2021
Q4
$381K Sell
1,654
-205
-11% -$50.1K ﹤0.01% 1288
2021
Q3
$433K Buy
+1,859
New +$388K ﹤0.01% 1257

Other funds holding INSP

Pictet Asset Management (Switzerland)'s INSP Position: Q2 2023 in Review

Pictet Asset Management (Switzerland) held its Inspire Medical Systems (INSP) position steady in Q2 2023 at 3,363 shares worth $1.09M. The position accounts for ﹤0.01% of the portfolio, ranked #976.

Pictet Asset Management (Switzerland) first reported a position in INSP in Q3 2021 and has held it in 8 quarters since. 407 funds tracked by Wall St. Rank hold INSP as of Q2 2023.

  • Pictet Asset Management (Switzerland) held 3,363 shares of Inspire Medical Systems worth $1.09M as of Q2 2023.
  • Pictet Asset Management (Switzerland) left its Inspire Medical Systems share count unchanged in Q2 2023.
  • Inspire Medical Systems made up ﹤0.01% of Pictet Asset Management (Switzerland)'s portfolio in Q2 2023, its #976 holding.
  • Pictet Asset Management (Switzerland) first reported a position in Inspire Medical Systems in Q3 2021 and has held it in 8 quarters since.
  • 407 funds tracked by Wall St. Rank held Inspire Medical Systems as of Q2 2023.

Based on Pictet Asset Management (Switzerland)'s 13F filing for Q2 2023, filed 10 Aug 2023.